59
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review

, , , , , & show all
Pages 2767-2770 | Published online: 01 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinyu Song, Dawei Chen, Jun Guo, Li Kong, Haiyong Wang & Zhehai Wang. (2018) Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer. OncoTargets and Therapy 11, pages 8421-8426.
Read now

Articles from other publishers (3)

Yuto Terashima, Taiki Hakozaki, Susumu Takeuchi & Yukio Hosomi. (2022) Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report. Thoracic Cancer 13:23, pages 3408-3411.
Crossref
Dawei Chen, Xinyu Song, Fang Shi, Hui Zhu, Haiyong Wang, Nasha Zhang, Yan Zhang, Li Kong & Jinming Yu. (2016) Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion. Oncotarget 8:21, pages 35262-35271.
Crossref
Dawei Chen, Yan Zhang, Fang Shi, Hui Zhu, Minghuan Li, Kaijun Chen, Li Kong & Jinming Yu. (2016) Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients. Oncotarget 7:32, pages 52436-52441.
Crossref